VEON delivered a strong Q225, with revenue of $1,087m beating our estimate (3.4%) and underlying EBIT, (stripping out a $498m gain), of $322m, 13.2% ahead of our estimate. We have increased our adjusted EPS estimate by 3.4% to $5.33 in FY25 and 4.9% to $6.63 in FY26, and new reported EPS to $12.39
